| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |